All News

Selumetinib plus docetaxel did not slow progression in lung cancer any more than docetaxel alone.

When used in combination, Cotellic and Zelboraf showed a significant reduction in death rates for some patients with melanoma.

Volker Heinemann says early tumor shrinkage may be a better predictor than progression-free survival in colorectal cancer.

Jonathan Riess emphasizes the importance of testing for ROS1 and TRK in patients with lung cancer so that treatment options can be explored accordingly.

Post traumatic stress disorder can occur in women who've experienced the trauma of breast cancer.

Patients now have one more option to combat chemotherapy-induced nausea and vomiting after the FDA approval of Sustol.

CURE spoke with Celestia S. Higano on common problems that survivors of prostate cancer face.

While most survivors of childhood cancers are well adjusted, a recent study revealed that more testing is needed for psychosocial late effects in certain groups.

This is my wish list for all cancer survivors across all types of cancer who struggle with cancer's emotional isolation.

Chemotherapy-induced nausea and vomiting can be reduced with certain FDA-approved drugs.

A recent study proved that patients with early stage lung cancer who live in areas with poor air quality have shorter survival spans than those who live where the air quality is better.

Though it is a difficult subtype to treat right now, Cynthia Ma is optimistic about emerging treatment options for triple-negative breast cancer.

The words "cancer" and "thank you" don't usually go together.

Someone who has never experienced cancer may feel apprehensive about how to talk to someone who has been diagnosed. Here are my two cents about communicating with a cancer patient.

Two recent studies showed that insurance disparities could end up being treatment and survival disparities for patients with cancer.

ASCO and SGO just made new guidelines stating that neoadjuvant chemotherapy is the best first-line treatment for some women with ovarian cancer.

Opdivo failed to improve progression-free survival for patients with NSCLC in a recent study.

Barnes discusses discovering the value of inspiration in healing.

Challenging the insurance company for medical equipment is often frustrating, but persistence pays off.

An accelerated FDA approval has been granted to the immunotherapy Keytruda for patients with recurrent or metastatic head and neck squamous cell carcinoma following progression on a platinum-containing chemotherapy.

What can online searches tell about a potential cancer diagnosis? Scientists at Microsoft are interested in finding out.

What has been your experience with returning to work during and after cancer treatment? What would make the transition easier? Do you have advice to share with patients and survivors?

I'm writing my own chapter within a bigger story.

CURE spoke with Axel Grothey about advances in the treatment of colorectal cancer.

Adcetris met its primary endpoint in a phase 3 trial for patients with T-cell lymphoma.

A recent phase 3 study showed that Sutent extended disease-free survival for patients with renal cell carcinoma.

Knowing the possible risks for breast cancer is important, and some of them are within our control.

No follow-up scan is easy, but some feel routine. When they don't, we have no choice as survivors but to face our fears and move forward, one step at a time, one scan at a time.

Gregory Zagaja discusses the benefits of surgery for prostate cancer, as well as recent updates in the field.

A recent study revealed that people of color tend to have poorer prognoses than white people when diagnosed with melanoma.